References
- Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sørensen OH. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br. J. Nutr. 86(Suppl. 1), S97–S103 (2001).
- Kerr GS, Sabahi I, Richards JS et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J. Rheumatol. 38(1), 53–59 (2011).
- Gopinath K, Danda D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int. J. Rheum. Dis. 14(4), 332–339 (2011).
- Furuya T, Hosoi T, Tanaka E et al. Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin. Rheumatol. doi:10.1007/s10067-013-2216-4 (2013) (Epub ahead of print).
- Haga HJ, Schmedes A, Naderi Y, Moreno AM, Peen E. Severe deficiency of 25-hydroxyvitamin D(3) (25-OH-D (3)) is associated with high disease activity of rheumatoid arthritis. Clin. Rheumatol. 32(5), 629–633 (2013).
- Turhanoglu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol. Int. 31(7), 911–914 (2011).
- Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum. 50(1), 72–77 (2004).
- Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 67(4), 530–535 (2008).
- Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin. Rheumatol. 31(12), 1733–1739 (2012).
- Oelzner P, Müller A, Deschner F et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif. Tissue Int. 62(3), 193–198 (1998).
- Rosini M, Maddali Bondi S, Montagna G et al. Vitamin D deficiency in rheumatod arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12(6), R216 (2010).
- Higgins MJ, Mackie SL, Thalayasingam N, Bingham SJ, Hamilton J, Kelly CA. The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis. Clin. Rheumatol. doi:10.1007/s10067-013-2174-x (2013) (Epub ahead of print).
- Reid D, Toole BJ, Knox S et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 93(5), 1006–1011 (2011).
- Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun. Rev. 12(2), 127–136 (2012).
- Peelen E, Knippenberg S, Muris AH et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10(12), 733–743 (2011).
- Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179(3), 1634–1647 (2007).
- Wen H, Baker JF. Vitamin D, immunoregulation, and rheumatoid arthritis. J. Clin. Rheumatol. 17(2), 102–107 (2011).
- Baker JF, Mehta NN, Baker DG et al. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am. J. Med. 125(10), 1036.e9–1036.e15 (2012).
- Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128(1), 68–72 (1998).
- Gopinath K, Danda D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int. J. Rheum. Dis. 14(4), 332–339 (2011).